168 related articles for article (PubMed ID: 19350199)
1. Beneficial effects of astragalus polysaccharides treatment on cardiac chymase activities and cardiomyopathy in diabetic hamsters.
Chen W; Yu MH; Li YM; Chen WJ; Xia YP
Acta Diabetol; 2010 Dec; 47 Suppl 1():35-46. PubMed ID: 19350199
[TBL] [Abstract][Full Text] [Related]
2. Effects of Astragalus polysaccharides on chymase, angiotensin-converting enzyme and angiotensin II in diabetic cardiomyopathy in hamsters.
Chen W; Li YM; Yu MH
J Int Med Res; 2007; 35(6):873-7. PubMed ID: 18035000
[TBL] [Abstract][Full Text] [Related]
3. Astragalus polysaccharides inhibited diabetic cardiomyopathy in hamsters depending on suppression of heart chymase activation.
Chen W; Li YM; Yu MH
J Diabetes Complications; 2010; 24(3):199-208. PubMed ID: 19230716
[TBL] [Abstract][Full Text] [Related]
4. Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase.
Liu W; Chen J; Xu T; Tian W; Li Y; Zhang Z; Li W
Am J Hypertens; 2012 Feb; 25(2):250-60. PubMed ID: 22089109
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.
Dong B; Yu QT; Dai HY; Gao YY; Zhou ZL; Zhang L; Jiang H; Gao F; Li SY; Zhang YH; Bian HJ; Liu CX; Wang N; Xu H; Pan CM; Song HD; Zhang C; Zhang Y
J Am Coll Cardiol; 2012 Feb; 59(8):739-47. PubMed ID: 22340266
[TBL] [Abstract][Full Text] [Related]
6. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload.
Li P; Chen PM; Wang SW; Chen LY
Hypertens Res; 2002 Sep; 25(5):757-62. PubMed ID: 12452330
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells.
Lavrentyev EN; Estes AM; Malik KU
Circ Res; 2007 Aug; 101(5):455-64. PubMed ID: 17626897
[TBL] [Abstract][Full Text] [Related]
9. Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters.
Shimizu M; Tanaka R; Uchida M; Orito K; Shimamura S; Yamane Y
J Vet Med Sci; 2006 Mar; 68(3):227-33. PubMed ID: 16598165
[TBL] [Abstract][Full Text] [Related]
10. Improvement of myocardial glycolipid metabolic disorder in diabetic hamster with Astragalus polysaccharides treatment.
Chen W; Xia YP; Chen WJ; Yu MH; Li YM; Ye HY
Mol Biol Rep; 2012 Jul; 39(7):7609-15. PubMed ID: 22426864
[TBL] [Abstract][Full Text] [Related]
11. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin I converting enzyme and chymase in cardiovascular tissues.
Nishimura H; Hoffmann S; Baltatu O; Sugimura K; Ganten D; Urata H
Kidney Int Suppl; 1996 Jun; 55():S18-23. PubMed ID: 8743505
[TBL] [Abstract][Full Text] [Related]
13. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart.
Shiota N; Fukamizu A; Takai S; Okunishi H; Murakami K; Miyazaki M
J Hypertens; 1997 Apr; 15(4):431-40. PubMed ID: 9211178
[TBL] [Abstract][Full Text] [Related]
14. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
Urata H; Ganten D
Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
[TBL] [Abstract][Full Text] [Related]
15. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters.
Takai S; Jin D; Sakaguchi M; Katayama S; Muramatsu M; Sakaguchi M; Matsumura E; Kim S; Miyazaki M
J Pharmacol Exp Ther; 2003 Apr; 305(1):17-23. PubMed ID: 12649348
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
17. Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2+/-) knockout mice.
Ju J; Chen W; Lai Y; Wang L; Wang H; Chen WJ; Zhao X; Ye H; Li Y; Zhang Y
Braz J Med Biol Res; 2017 Jul; 50(8):e6204. PubMed ID: 28700033
[TBL] [Abstract][Full Text] [Related]
18. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
Miyazaki M; Takai S; Jin D; Muramatsu M
Pharmacol Ther; 2006 Dec; 112(3):668-76. PubMed ID: 16837049
[TBL] [Abstract][Full Text] [Related]
19. Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-kappaB and IkappaB in renal cortex of streptozotoxin-induced diabetic rats.
Zhang YW; Wu CY; Cheng JT
J Ethnopharmacol; 2007 Dec; 114(3):387-92. PubMed ID: 17900838
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of angiotensin-converting enzyme inhibition in adriamycin-induced cardiomyopathy in hamsters.
Okumura K; Jin D; Takai S; Miyazaki M
Jpn J Pharmacol; 2002 Feb; 88(2):183-8. PubMed ID: 11928719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
